Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Atrogi’s ATR-258 breakthrough: muscle-targeted β2-agonist mimics exercise to treat obesity, diabetes, and muscle loss Atrogi’s ATR-258 mimics exercise through skeletal muscle targeting to reduce fat and preserve muscle, redefining obesity and diabetes therapies. bySoujanya RaviJune 23, 2025